Brought to you by 
Pozen and Tribute combine to form Aralez Pharmaceuticals
Jun 2015
Executive Summary
US biotech Pozen Inc. paid $146mm to acquire public Canadian company Tribute Pharmaceuticals Canada Inc., forming Aralez Pharmaceuticals PLC, which will trade on Nasdaq and TSX and be domiciled in Ireland.
Deal Industry
-
Biotechnology
- Large Molecule
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pozen and Tribute combine to form Aralez Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice